Last updated: December 16, 2024
Sponsor: University College, London
Overall Status: Active - Recruiting
Phase
N/A
Condition
Panic Disorders
Anxiety Disorders
Obsessive-compulsive Disorder
Treatment
N/AClinical Study ID
NCT05520398
15/0541
Ages 18-55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of obsessive-compulsive disorder (OCD)
Fluent in written and spoken English
Normal/corrected to normal vision
Expecting to start OCD therapy
Exclusion
Exclusion Criteria:
Autism spectrum disorder, psychosis, schizophrenia, addiction, substance abuse,bipolar, hoarding, or Tourette disorder
Hearing conditions: tinnitus, ear inflammation, hearing sensitivity, hearing loss,requires hearing aids
Colour blindness
Severe learning disabilities
Study Design
Total Participants: 90
Study Start date:
November 10, 2021
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Max Planck UCL Centre for Computational Psychiatry and Ageing Research
London, WC1B 5EH
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.